{
  "schema_version": 1,
  "kind": "condition",
  "id": "acute-vomiting-adult",
  "name": "Acute Vomiting (adult, non-surgical)",
  "category": "acute",
  "sources": "NICE Clinical Knowledge Summaries: Nausea and vomiting 2021 · Egyptian National Drug Formulary 2026 · Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (ondansetron monograph) · Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (metoclopramide monograph) · Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (granisetron monograph)",
  "review_status": "reviewed",
  "verified_against": "Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (ondansetron monograph) · Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (metoclopramide monograph) · Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (granisetron monograph)",
  "verified_date": "2026-08",
  "treatments": [
    {
      "id": 108,
      "generic": "Ondansetron",
      "line": 1,
      "is_adjunct": false,
      "form": "oral.solid",
      "strength_mg": 4.0,
      "adult_dose": "4-8 mg orally (or 4-8 mg slow IV/IM) every 8 hours PRN for severe acute non-surgical vomiting",
      "adult_duration": "1-3 days PRN",
      "dose_source": "Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (ondansetron monograph)",
      "rationale": "Effective 5-HT3 receptor antagonist available in Egypt (Danofran, Danset); used off-label in primary care for acute gastroenteritis vomiting as an alternative to dopamine antagonists.",
      "cautions": [
        "Surgical causes of acute abdomen (appendicitis, bowel obstruction, acute cholecystitis) MUST be excluded before administering antiemetics.",
        "May prolong QT interval; exercise caution in patients with long QT syndrome, electrolyte disturbances, or concomitant QT-prolonging drugs.",
        "Common side effects include headache, flushing, and constipation.",
        "The formulary's ondansetron dosing covers chemotherapy and radiotherapy nausea, where the adult dose is 8 mg. Use for acute non-surgical vomiting is not a licensed indication in the formulary.",
        "Contraindicated in hypersensitivity to ondansetron or any component of the formulation, and in concomitant use with apomorphine."
      ],
      "peds_mgkg_low": null,
      "peds_mgkg_high": null,
      "peds_max_mg": null,
      "peds_basis": null,
      "peds_unit": null,
      "peds_note": "Not routinely indicated for mild childhood vomiting; in acute gastroenteritis with dehydration, single oral dose (0.15 mg/kg, max 8 mg) may be given under clinical supervision",
      "peds_min_weight_kg": null,
      "peds_max_weight_kg": null,
      "peds_age_min_months": null,
      "peds_age_max_months": null,
      "peds_age_bands": null,
      "peds_doses": null,
      "brands": [
        {
          "trade_name": "DANOFRAN 4MG 5 F.C. TAB.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "UP PHARMA",
          "price_egp": 70.0,
          "pack_count": 5,
          "unit_price": 14.0,
          "strength_mg": 4.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "SETRONOMET 4 MG 4 ORAL DIS. TABS.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "AVERROES PHARMA",
          "price_egp": 78.0,
          "pack_count": null,
          "unit_price": null,
          "strength_mg": 4.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "IDIVOMTRON 4 MG 10 ORALLY DIS. TABS.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "INTERNATIONAL DRUG AGENCY (IDI)",
          "price_egp": 144.0,
          "pack_count": null,
          "unit_price": null,
          "strength_mg": 4.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "EMEREST 4 MG 10 ORO-DISPERSIBLE TABS.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "GLOBAL PHARMACEUTICAL INDUSTRIES",
          "price_egp": 188.0,
          "pack_count": null,
          "unit_price": null,
          "strength_mg": 4.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "IDIVOMTRON 4 MG/5ML SYRUP 50 ML",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "RAMEDA > INTERNATIONAL DRUG AGENCY (IDI)",
          "price_egp": 110.0,
          "pack_count": null,
          "unit_price": null,
          "strength_mg": 4.0,
          "exact_strength": false,
          "exact_form": false,
          "discontinued": false,
          "also_contains": null
        }
      ],
      "condition_id": "acute-vomiting-adult"
    },
    {
      "id": 109,
      "generic": "Metoclopramide",
      "line": 2,
      "is_adjunct": false,
      "form": "oral.solid",
      "strength_mg": 10.0,
      "adult_dose": "10 mg orally (or IM/IV) up to three times daily (max 30 mg/day or 0.5 mg/kg/day)",
      "adult_duration": "Up to 5 days max",
      "dose_source": "Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (metoclopramide monograph)",
      "rationale": "Prokinetic dopamine D2 antagonist registered in Egypt (Meclopram, Clopram) for acute nausea and vomiting of gastrointestinal origin",
      "cautions": [
        "There is a high risk of extrapyramidal side effects (acute dystonic reactions, oculogyric crisis), especially in young adults and females; strictly limit duration to max 5 days.",
        "Contraindicated in mechanical gastrointestinal obstruction, perforation, or phaeochromocytoma.",
        "Reduce dose in renal or hepatic impairment.",
        "Contraindicated in epilepsy, in Parkinson's disease, and in combination with levodopa or a dopaminergic agonist."
      ],
      "peds_mgkg_low": null,
      "peds_mgkg_high": null,
      "peds_max_mg": null,
      "peds_basis": null,
      "peds_unit": null,
      "peds_note": "Pediatric patients aged 1-18 years \nNausea and vomiting indications (as a second-line agent) \n• Oral, IM, IV: 0.1 to 0.15 mg/kg, repeated up to three times daily.",
      "peds_min_weight_kg": null,
      "peds_max_weight_kg": null,
      "peds_age_min_months": null,
      "peds_age_max_months": null,
      "peds_age_bands": [
        {
          "label": "1 to 18 years",
          "age_min_months": 12,
          "age_max_months": 216,
          "dose_text": "Second line only: 0.1 to 0.15 mg/kg by mouth, IM or IV, repeated up to three times daily"
        }
      ],
      "peds_doses": null,
      "brands": [
        {
          "trade_name": "CLOPRAM 10MG 20 TAB.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "EL NASR",
          "price_egp": 3.0,
          "pack_count": 20,
          "unit_price": 0.15,
          "strength_mg": 10.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "PLEMAZOL 10MG 20 TAB.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "CID",
          "price_egp": 3.2,
          "pack_count": 20,
          "unit_price": 0.16,
          "strength_mg": 10.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "VOMAWAY 10MG 20 TAB.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "MEMPHIS",
          "price_egp": 8.5,
          "pack_count": 20,
          "unit_price": 0.42,
          "strength_mg": 10.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "PRIMPERAN 10MG 10 SCORED TAB.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "SANOFI",
          "price_egp": 10.5,
          "pack_count": null,
          "unit_price": null,
          "strength_mg": 10.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        }
      ],
      "condition_id": "acute-vomiting-adult"
    },
    {
      "id": 110,
      "generic": "Granisetron",
      "line": 3,
      "is_adjunct": false,
      "form": "oral.solid",
      "strength_mg": 1.0,
      "adult_dose": "1 mg twice daily or 2 mg once daily by mouth; the first dose is taken 1 hour before the emetogenic stimulus",
      "adult_duration": "Up to one week",
      "dose_source": "Egyptian National Drug Formulary - Gastrointestinal Tract 2025 (granisetron monograph)",
      "rationale": "15 live products. A 5-HT3 antagonist alternative for a patient who has not responded to or cannot take ondansetron; the oral tablet and 1 mg/5 mL solution are both on the Egyptian market.",
      "cautions": [
        "The licensed indications are chemotherapy-induced, radiotherapy-induced and post-operative nausea - use in undifferentiated acute vomiting is outside the licence.",
        "Ondansetron is already in this condition, is cheaper, and has far more evidence in general acute vomiting - granisetron is a second choice, not an upgrade.",
        "Do not use an antiemetic to mask an undiagnosed surgical abdomen; examine first.",
        "Class QT prolongation - avoid in a patient already on another QT-prolonging drug.",
        "Stop for serotonin syndrome (agitation, clonus, hyperreflexia, fever), particularly in a patient on an SSRI or SNRI.",
        "Avoid combination with Apomorphine (Risk X interaction).",
        "The maximum is 9 mg in 24 hours by any route."
      ],
      "peds_mgkg_low": null,
      "peds_mgkg_high": null,
      "peds_max_mg": null,
      "peds_basis": null,
      "peds_unit": null,
      "peds_note": "The formulary gives paediatric dosing only for the intravenous route (10-40 micrograms/kg, up to 3 mg, in children 2 years and over) and only for chemotherapy or radiotherapy nausea. There is no oral paediatric dose - do not extrapolate one.",
      "peds_min_weight_kg": null,
      "peds_max_weight_kg": null,
      "peds_age_min_months": null,
      "peds_age_max_months": null,
      "peds_age_bands": null,
      "peds_doses": null,
      "brands": [
        {
          "trade_name": "EMETOVOID 1 MG 10 F.C.TABS.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "SEDICO",
          "price_egp": 72.0,
          "pack_count": 10,
          "unit_price": 7.2,
          "strength_mg": 1.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "EM-EX 1 MG 10 F.C.TABS.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "AMOUN",
          "price_egp": 200.0,
          "pack_count": 10,
          "unit_price": 20.0,
          "strength_mg": 1.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "GRANITRYL 1 MG 5 F.C.TABS.",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "INTERNATIONAL DRUG AGENCY (IDI) > EGYPHARMA-EGYPT",
          "price_egp": 202.0,
          "pack_count": 5,
          "unit_price": 40.4,
          "strength_mg": 1.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        },
        {
          "trade_name": "GRANITRYL 1MG/5ML ORAL SOLUTION 30 ML",
          "scientific_name": null,
          "normalized_ingredient": null,
          "manufacturer": "DELTA GRAND > EGYPHARMA-EGYPT",
          "price_egp": 226.0,
          "pack_count": null,
          "unit_price": null,
          "strength_mg": 1.0,
          "exact_strength": true,
          "exact_form": true,
          "discontinued": false,
          "also_contains": null
        }
      ],
      "condition_id": "acute-vomiting-adult"
    }
  ]
}